Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline versus tigecycline for complicated intra-abdominal infections in ICU patients
ChiCTR2300078646Phase 3Recruiting
- Sponsor
- Anshan Hospital of China Medical University
- Start
- Dec 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in Intra-abdominal infection (IAI) comparing Eravacycline group with Tigecycline group (2 arms). Primary endpoint: 30-day all-cause mortality rate. Started Dec 2023; status: recruiting.
02
Drugs
eravacyclinetigecycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on ChiCTR2300078646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078646.